학술논문
Phase II study of gemcitabine (G) and bevacizumab (B) as first-line treatment in taxane-pretreated, HER2-negative, locally recyrrent or metastatic breast cancer (MBC): Interim safety analysis
Document Type
Journal
Source
Subject
Language
English
ISSN
15277755